Inventor
JENSEN KLAUS GJERVIG
DK20 patents
⚠️ This page may combine multiple inventors who share the name “JENSEN KLAUS GJERVIG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
H LUNDBECK AS
16 patentsUS11707476B2Jul 25, 2023
Catecholamine prodrugs for use in the treatment of parkinson's disease
H LUNDBECK AS12 citations93
US11110110B2Sep 7, 2021
Catecholamine prodrugs for use in the treatment of Parkinson's disease
H LUNDBECK AS15 citations93
US10729710B2Aug 4, 2020
Catecholamine prodrugs for use in the treatment of Parkinson's disease
H LUNDBECK AS21 citations93
US11130775B2Sep 28, 2021
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
H LUNDBECK AS14 citations92
US12226428B2Feb 18, 2025
Catecholamine prodrugs for use in the treatment of Parkinson's disease
H LUNDBECK AS6 citations85
US11858954B2Jan 2, 2024
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
H LUNDBECK AS8 citations83
US11059798B2Jul 13, 2021
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
H LUNDBECK AS3 citations83
US10501427B2Dec 10, 2019
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
H LUNDBECK AS4 citations83
US10118907B2Nov 6, 2018
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
H LUNDBECK AS5 citations83
US9617231B2Apr 11, 2017
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
H LUNDBECK AS5 citations83
US12116355B2Oct 15, 2024
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
H LUNDBECK AS0 citations62
US12421271B2Sep 23, 2025
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
H LUNDBECK AS0 citations61
US12398106B2Aug 26, 2025
Catecholamine carbamate prodrugs for use in the treatment of parkinson's disease
H LUNDBECK AS0 citations52
US12384765B2Aug 12, 2025
Catecholamine prodrugs for use in the treatment of Parkinson's Disease
H LUNDBECK AS0 citations51
US12319710B2Jun 3, 2025
Catecholamine prodrugs for use in the treatment of Parkinson's diseases
H LUNDBECK AS0 citations51
US12391650B2Aug 19, 2025
Catecholamine prodrugs for use in the treatment of Parkinson's disease
H LUNDBECK AS0 citations50
LUNDBECK & CO AS H
3 patentsUS7772240B2Aug 10, 2010
Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
LUNDBECK & CO AS H56 citations94
US9012453B2Apr 21, 2015
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
LUNDBECK & CO AS H9 citations92
US9216961B2Dec 22, 2015
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
LUNDBECK & CO AS H5 citations83